Combined chemotherapy of irinotecan/platinum in extensive disease SCLC
10.11904/j.issn.1002-3070.2015.01.015
- VernacularTitle:伊立替康联合铂类药物治疗广泛期 SCLC 的研究进展
- Author:
Xiaofeng ZHU
;
Jiemei ZHU
- Publication Type:Journal Article
- Keywords:
Irinotecan;
Platinum;
Extensive disease small cell lung cancer
- From:
Practical Oncology Journal
2015;(1):69-72
- CountryChina
- Language:Chinese
-
Abstract:
Small cell lung cancer(SCLC),characterized with rapid growth and early metastasis ,accounts for about 15~20 percent of all kinds of lung cancer .Patients with extensive disease of SCLC should be treated with combined chemotherapy .The standard treatment for extensive SCLC is etoposide combined with platinum , shortly for EP,with no breakthrough progress in the last decades .This paper briefly reviews the combination of iri-notecan/platinum that showed effectiveness and safety in the treatment of extensive SCLC .
